New IDH1 Inhibitor Wins FDA Approval for Acute Myeloid Leukemia Olutasidenib led to a 35% response rate in a study of adults with previously treated AML Dec 02, 2022
Stop Passing Off Politics as Evidenced-Based Medicine Scientific results cannot be understood through a framework of rigid political doctrine Dec 01, 2022
FDA Greenlights First Fecal Microbiota Product Rebyota approved for preventing recurrence of C. difficile infection Dec 01, 2022
As He Steps Down, Fauci Urges Everyone to Get Flu, COVID Vaccines Asked about his legacy, he says he's "never left anything on the field" Nov 22, 2022
Watch for Severe Hypocalcemia in Dialysis Patients on Prolia, FDA Warns Agency said potential risk may require more frequent blood calcium monitoring Nov 22, 2022
CDC's Updated Opioid Guidelines Are Necessary, but Not Sufficient Additional steps are needed to calibrate opioid access and undo harm Nov 18, 2022
FDA Approves First Drug to Delay Onset of Type 1 Diabetes Teplizumab will not be subject to a risk evaluation and mitigation strategy program, after all Nov 18, 2022
FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus Control Advisors see need for alternatives, citing suboptimal efficacy and tolerance of approved options Nov 17, 2022
AMA Edges Closer to Supporting Public Option Members will also oppose employer mandates requiring docs to sign contracts waiving due process Nov 16, 2022
After Rejection, Tenapanor for Kidney Disease Faces FDA's Outside Experts Drug's effect on serum phosphorus "small and of unclear clinical significance," say FDA reviewers Nov 15, 2022
FDA OKs First Antibody-Drug Conjugate for Platinum-Resistant Ovarian Cancer Mirvetuximab soravtansine produced responses in almost a third of patients in pivotal trial Nov 15, 2022
Results Mixed for Docs Running for Congress Incumbents did better than challengers; some races still up in the air Nov 14, 2022
Expanding Vaccination Pay, 'Public Option' Fuel Debate Among AMA Delegates Resolutions also advocate for greater accuracy in Medicare Advantage plan offerings and more Nov 14, 2022
Another Adalimumab Biosimilar Seems Set for Interchangeability Trial data pave way for FDA approval Nov 14, 2022
AMA President Says 'Enough is Enough' to Divisive Politics, Fake News in Medicine "We cannot allow physicians or our patients to become pawns," says Jack Resneck Jr., MD Nov 13, 2022
A Remedy for the Federally Funded Physician Shortage Raising or eliminating the cap on residency spots can make all the difference Nov 13, 2022
FDA Authorizes IL-1 Drug for Hospitalized COVID Patients Anakinra indicated for patients with pneumonia who are at risk of severe respiratory failure Nov 09, 2022
Internal Strife at America's Frontline Doctors: Simone Gold Accused of Misusing $$$ Nasty fight now a federal lawsuit; Gold tries to regain company control Nov 07, 2022
COVID Spread Through Floors, Walls; Infant Pillow Warning; Paul Pelosi Discharged Health news and commentary from around the Web gathered by ทฌวัษ็ว๘ staff Nov 04, 2022
The USPSTF Process Is in Jeopardy A recent U.S. District Court ruling challenges the legitimacy of all task force recommendations Nov 02, 2022
Pulse Oximeters Need to Work Better for Dark-Skinned Patients, FDA Panel Says Warnings to patients and providers, improved accuracy needed, advisors say Nov 02, 2022
Regulators Move Against Two 'Misinformation' Doctors Peter McCullough, MD, and Sherri Tenpenny, DO, face new scrutiny Nov 01, 2022
'Pill Mill' Docs, You May Be in for a Big Scare Two recent Supreme Court cases have major implications for physician practice Oct 27, 2022
The Updated COVID Boosters Could Have Been Better From design to implementation, our bivalent shots missed the mark Oct 26, 2022
FDA Broadens Options for Relapsed/Refractory Multiple Myeloma With Teclistamab Bispecific antibody achieved durable responses in a majority of heavily pretreated patients Oct 25, 2022
Makena Is Just the Latest in Accelerated Approval Mayhem Congress must take action to reform the process Oct 24, 2022
FDA Approves New CTLA-4 Inhibitor for Cancer Treatment Tremelimumab (Imjudo), in combination with durvalumab, lands approval in advanced liver cancer Oct 24, 2022
Thumbs Down for Genetic Test for Opioid Use Disorder, FDA Advisors Say False positives, false negatives remain a concern Oct 21, 2022
CMS Puts the Kibosh on Misleading Medicare Advantage Sales Pitches "Secret shoppers" found that 80% of agent calls with clients were inaccurate or insufficient Oct 21, 2022
Mayo Warns It Won't Take Most Medicare Advantage Plans Letters to Florida, Arizona patients suggest they enroll in original Medicare with a supplement Oct 20, 2022
Revoke Approval of Preterm Birth Drug, FDA Advisors Say Makena is ineffective, argued FDA panel Oct 19, 2022
Biden Promises to Codify Roe Protections Into Law if Democrats Win Midterms It will be "the first bill" I send to Congress in the new session, he said Oct 18, 2022
FDA Moves to Pull Controversial Preterm Birth Drug From the Market Briefing data show Makena was ineffective in reducing preterm birth, improving neonatal outcomes Oct 14, 2022
The Medicare Advantage Trade-Off: Saving Money, Losing Access Beneficiaries may spend less on premiums, but care delays are common. Do worse outcomes follow? Oct 13, 2022
Why I Voted 'No' on the New ALS Drug Here are the shortcomings I saw in the phase II Relyvrio study Oct 13, 2022
What Good Is a CPAP Machine Without a Microchip? The shortage threatens the well-being of patients with sleep apnea, among others Oct 11, 2022
FDA Approves At-Home Furosemide for Heart Failure Strong diuretic to become available outside the hospital setting Oct 10, 2022
FDA OKs Tdap Vaccine for Whooping Cough Protection Before Birth Boostrix vaccine is to be delivered to the unborn child in the third trimester of pregnancy Oct 07, 2022
The Search Is On for Another Xeno Heart Transplant Recipient Transplant surgeons discuss testing the concept in more humans Oct 04, 2022
FDA's Power Morcellator Warning Tied to Drop in Distant Leiomyosarcomas Local and regional illness remained unchanged Oct 04, 2022
